NEW ENGLAND HEALTHCARE EXECUTIVE MEETING DECEMBER 5, 2016, 7:30AM TO 10:00AM THE HUMAN MICROBIOME IS IT THE PANACEA FOR CANCER, AUTOIMMUNE AND INFLAMMATORY DISEASE? FOLEY HOAG LLP, Seaport West, 155 Seaport Boulevard, Boston For
NEW ENGLAND HEALTHCARE EXECUTIVE MEETING
DECEMBER 5, 2016, 7:30AM TO 10:00AM
THE HUMAN MICROBIOME
IS IT THE PANACEA FOR CANCER,
AUTOIMMUNE AND INFLAMMATORY DISEASE?
FOLEY HOAG LLP, Seaport West, 155 Seaport Boulevard, Boston
For Driving and Parking Information, Click Here.
The microbiome is the focus of many researchers interested in how ecological community of commensal, symbiotic and pathogenic microorganisms interact with our immune systems and contribute to the rise of multiple disorders. This research could have profound therapeutic implications in the treatment of cancer, diabetes, autoimmune and inflammatory disease.
- But what does this disruptive technology really mean for healthcare?
- Will engineered probiotic bacteria correct missing or dysfunctional metabolic activities throughout the body?
- Human Microbiome Project Initiative – what can Federal involvement due to enable research?
- What opportunities are there to develop new therapeutics for patients across multiple disease areas?
- Do inflammatory microbes in our gut increase our risk for diabetes and autoimmune disorders and can intervention prevent these diseases?
- What can we learn from the hygiene hypothesis and modify our lifestyles and live longer?
- Will therapeutic options for care lead to lower cost and improved patient outcomes?
Come join this timely, lively, blue ribbon panel of experts. Ask them questions and contribute your insights during the audience interactive segment.
James J. Collins, Ph.D., Termeer Professor of Medical Engineering & Science, Professor, Department of Biological Engineering Massachusetts Institute of Technology
John Brooks, Managing Director, Healthcare Capital
David Barry, General Partner, Flagship Ventures
JC Gutiérrez-Ramos, Ph.D., CEO, Synlogic Therapeutics
Who Should Attend:
CEOs, CTOs, CFOs, clinicians, technologists, investors, and business experts seeking a better understanding of the potential of the microbiome to change the lives of patients.
(Monday) 7:30 am - 10:00 am
Hilton Boston Logan Airport